CCL2 and systemic lupus erythematosus: With the exception of MCP-1, these mediators remained elevated pre- and post-transition in lupus relatives who developed ILE or SLE in both the LAUREL (Figures 4B, C) and LFRR (Figure 4D) cohorts.